Successive supply of chemotherapy drugs in the treatment of lung cancer, drugs available under the drug program for the treatment of lung cancer and pulmonary fibrosis

and antiemetics for WZZOZCLChPłiR in Łódź, 181 Okólna Street. The contracting authority: - does not provide for the use of an electronic auction, - does not make progress. in order to conclude a framework agreement, -does not reserve the possibility of applying for the award of contracts. only by the Contractors referred to in Article 94Pzp, - does not specify additional requirements related to the employment of persons referred to in Article 96 paragraph 2 point 2 of the PPL, - does not provide for reimbursement of the costs of participation in the proceedings., - does not make the reservations referred to in Article 60 and Article 121 of the PPL, - does not provide for the requirements referred to in Article 95 of the PPL, - does not provide for granting advances for the performance of orders., -does not provide for the award of contracts referred to in Article 214(1)(8) of the PPL. The Contractor may entrust the performance of part of the contracts. subcontractors(s).

Package 1 includes 22 assortment items: item 1 Carboplatinum inj., concentrate 150mg, vial 40, item 2 Carboplatinum inj., concentrate 450mg, vial 40, item 3 Carboplatinum inj., concentrate 600mg, vial 400, pos. 4 Etoposidum inj., concentrate 100mg, vial 10, pos. 5 Etoposidum inj., concentrate 200mg, vial 1000, pos. 6 Cisplatinum inj., concentrate 1mg/1ml fl 50ml, 250 violet,

pos. 7 Cisplatinum inj., concentrate 1mg/1ml fl 10ml, vial 10, pos. 8 Doxorubicini h/ch inj. concentrate 50mg, vial 30, pos. 9 Doxorubicini h/ch inj. concentrate 10mg, vial 10, pos. 10 Docetaxelum inj. 20mg, vial 80, pos. 11 Docetaxelum inj. 80mg, vial 160, pos. 12 Gemcitabini h/ch inj, concentrate, vial of not more than 50 ml, 2000mg, vial 140, item 13 Gemcitabini h/ch inj, concentrate, vial of not more than 25 ml, 1000mg, vial 30, item 14 Gemcitabini h/ch inj, concentrate, vial of not more than 5 ml, 200mg, vial of 10, item 15 Vinorelbinum inj. 10mg, pcs 500, pos. 16 Vinorelbinum inj. 50mg, pcs 500, item 17 Pemetrexedum inj. 100mg, vial 150, pos. 18 Pemetrexedum inj. 500mg vial 250, pos. 19 Paclitaxelum concentrate for solution for infusion. 30mg, vial 5, pos. 20 Paclitaxelum concentrate for solution for infusion. 100mg vial 25, pos. 21 Paclitaxelum concentrate for solution for infusion. 150mg vial 10, pos. 22 Paclitaxelum concentrate for solution for infusion. 300mg, 20 vial.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 10 includes 4 items assort.: pos. 1 Brigatinibum coated tabl 90mg + 180mg 7 tabl + 21 tabl. 1, pos. 2 Brigatinibum tabl coated 30mgX 28 pcs 1,

pos. 3 Brigatinibum coated tabl 90mg X 28 pcs 1, pos. 4 Brigatinibum tabl coated 180mgX 28 pcs 20.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 11 covers 1 item of sort.: pos. 1 Ceritinibum hard caps 150mgX150 pcs 3.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 12 includes 2 items: item 1 Durvalumabum concentrate for solution for infusion 120 mg/ 2.4 ml, vial 3, pos. 2 Durvalumabum concentrate for solution for infusion 500 mg / 10 ml, vial 100.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 13 includes 2 assorted items: item 1 Nintedanibum kaps, indicated for use in adults in the treatment of idiopathic pulmonary fibrosis 150mgx 60 pcs. 180,

pos. 2 Nintedanibum kaps, indicated in adults for the treatment of idiopathic pulmonary fibrosis 100mgx 60 pcs. 70.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 14 includes 2 assortment items: 1 Nivolumabum, concentrate for solution for infusion 10mg/ml, 4ml vial 260, pos. 2 Nivolumabum, concentrate for solution for infusion 10mg/ml, vial 10ml, vial 520.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 15 includes 2 assorted items: item 1 Osimertinibum tabl. Powl. 40mgX 30 pcs. 2, item 2 Osimertinibum tabl. Powl. 80mgX30 pcs 70.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 16 includes 2 items: item 1 Pirfenidonum tabl. 801mgX 84 pcs 100, pos. 2 Pirfenidonum kaps/tabl. 267mgX 252 pcs 20.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 17 covers 1 item of sort.: pos. 1 Pembrolizumabum, powder for solution for infusion 100mg, vial 300.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 18 covers 1 assorted position: pos. 1 Darbepoetinum alfa solution for injection 500 mcg/ml, Amp-strz. 45.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 19 covers 1st sorted position: item 1 Netupitantum+Palonosetroni h/chlorine. 300mg + 0.5mg X 1 caps. 90.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 2 includes 2 assortment items: item 1 Cyclophosphamidum inj. 200mg, vial 20, pos. 2 Cyclophosphamidum inj. 1000mg, 40 vial.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 20 includes 3 sorted items: item 1 Ondansetronum inj. 2mg/1ml ; AMP. 4 mlX 5 amp. 400, item 2 Ondansetronum inj. 2mg/1ml ; AMP. 2 mlX 5 amp. 10,

pos. 3 Ondansetronum tabl. orodispersible 8 mg x 10 tabl.x10 tabl. 10.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 21 includes 2 items of sort.: pos. 1 Ipilimumabum 50mg/10mlx 1violet. 20, pos. 2 Ipilimumabum 200mg/40mlx 1vial. 10.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 22 includes 1 item of sort.: pos. 1 Entrectinibum 200 mg X 90 tabl. 12.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 23 includes 1 item of sort.: pos. 1 Cemiplimabum 350 mg/7 ml x1 vial. 50.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 3 includes 3 items assort.: pos. 1 Erlotinibum tablets 150mgX 30 tabl. 2, pos. 2 Erlotinibum tablets 100mgX 30 tablets. 10, pos. 3 Erlotinibum tablets 25mgX 30 tablets. 1.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 4 covers 1 sorted position: item 1 Gefitinibum tabl powl. 250mgx 30tabl, 5

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 5 includes 2 assorted items: item 1 Topotecanum inj., concentrate. Vial 1mg/1ml, vial 1ml 250, pos. 2 Topotecanum inj., concentrate. 1mg/1ml vial, 4ml vial 150.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 6 covers 1 item assort.: item 1 Vincristini sulfas inj solution 1mg, pcs. 30.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 7 includes 3 items: pos. 1 Pegfilgrastimum solution for injection 6mg amp-strz. 20, item 2 Filgrastim 30 million. IU /0.5 ml amp-strz. 80, item 3 Filgrastim

48 million IU/0.5 ml amp-strz. 120.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 8 includes 3 assortment items: item 1 Afatinibum film-coated tablets 40mgX 28 pcs. 5, pos. 2 Afatinibum film-coated tablets 30mgX 28 pcs. 25, pos. 3 Afatinibum film-coated tablets 20mgX 28 pcs. 3.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.

Package 9 includes 3 items of sort.: item 1 Alectinibum hard caps 150mgX 224 pcs. 20, pos. 2 Atezolizumabum , concentrate for solution for infusion 1200mg/20ml vial 300, pos. 3 Atezolizumabum , concentrate for solution for infusion 840 mg/14 ml, vial 120.

The estimated description is included in the Assortment and Price Form constituting Annex 2 to the SWZ. The Ordering Party requires that the offered subject of the contract meets the requirements set out in applicable law, has been admitted to trading and has the documents required by law confirming the admission to use in the Polish. The subject of the contract must be admitted to trading and use in accordance with the provisions of the Act of 6 September 2001 Pharmaceutical Law (consolidated text, Journal of Laws of 2021, item 974, as amended) and have a certificate of registration of the Ministry of Health.